Healthcare Global Enterprises Q2 FY27: revenue up 13.1% to ₹732 Cr, net profit down 55.6% to ₹9 Cr
Results · Finvezto · 5 Nov 2026 · Healthcare Global Enterprises (HCG)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 732 | +5.3% | +13.1% |
| Operating profit | 133 | +9.1% | +8.2% |
| Net profit | 9 | -44.2% | -55.6% |
| Operating margin | 18.2% | +0.6 pp | -0.8 pp |
| Net margin | 1.3% | -1.1 pp | -1.9 pp |
Key points
- HealthCare Global Enterprises reported consolidated revenue from operations of Rs 731.80 crore for Q2 FY27, up 15.8% year-on-year, with adjusted EBITDA rising 17.2% to Rs 142.50 crore and adjusted profit after tax declining 9.3% to Rs 19.20 crore. NSE filing
- Performance was driven by a 9% rise in patient volumes, 7% growth in ARPP, and expansion in advanced oncology treatments. NSE filing
- Revenue was ₹732 Cr, up 13.1% on a year earlier and up 5.3% on the quarter before. Finvezto data
What to watch
- Operating margin over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26): 17.3%, 19.2%, 17.6%, 18.2%.
- Net profit over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26), ₹ Cr: -8, 4, 17, 9.
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.